Analysis: Kevin Hern's sell of UNH (UnitedHealth Group Incorporated)

Assessment: On watch

Ways and Means member's sale of UnitedHealth Group is heavily mitigated by its execution within a large multi-asset rebalancing batch and stale legislative catalysts.

Member: Kevin Hern
Party / state: R-OK (district 1)
Chamber: House
Transaction: Sell
Amount: $15,001 - $50,000
Ticker: UNH
Company: UnitedHealth Group Incorporated
Trade date: 2026-09-23
Disclosure date: 2026-10-13
Disclosure lag: 20 days

Executive summary

Kevin Hern (House, R-OK; Ways and Means member on Health and Tax subcommittees per user-provided input) reported a sale of UnitedHealth Group (UNH) on 2026-09-23 for $15,001-$50,000, disclosed on 2026-10-13. Congress.gov results show Ways and Means committee activity in 2026 on Medicare Advantage and prior authorization topics (including H.R.3514), which are policy areas relevant to large Medicare Advantage organizations. SEC EDGAR filings in the provided window show UNH filed 8-Ks for earnings and an investor-conference Reg FD disclosure; provided Form 4 activity consisted of code A grants/awards (no open-market insider buys/sells listed in the provided extract).

The analyzed UNH sale occurred as part of a same-day batch of multiple sales across several tickers and sectors (user-provided same-day activity list). Congress.gov sources show Medicare Advantage and prior-authorization-related legislative activity in 2026 (including H.R.3514 with Ways and Means involvement and a July 2026 Ways and Means meeting listing multiple healthcare-related bills), but this run did not complete a floor calendar review. Federal Register sources within the broader period include company-specific DOJ antitrust notices (UnitedHealth/Amedisys) and industry-wide rules/proposed rules affecting Medicare Advantage/Part D and PBM transparency; no attempt was completed to map these documents to specific near-trade effective dates beyond the excerpts captured. This run was limited by an automated web search results cap, preventing retrieval of UNH’s latest 10-K risk-factor excerpts and preventing completion of USAspending and news checks.

Timeline

2026-07-15 — H.R.3514 latest action shown as ordered to be reported (Ways and Means activity shown on bill page).
2026-07-16 — UNH filed 8-K reporting Q2 2026 results (Items 2.02, 9.01) with earnings release exhibit.
2026-09-08 — UNH filed 8-K (Item 7.01) about leadership participating in interview/Q&A at Wells Fargo annual healthcare conference (Reg FD disclosure).
2026-09-10 — Kevin Hern reported sale of UNH ($15,001-$50,000) in dataset prior to analyzed trade.
2026-09-23 — Kevin Hern sold UNH ($15,001-$50,000) (analyzed trade). Same-day batch also included sales of HD, DVN (two lots), CB, LMT, CVX, SBUX, MRSH.
2026-09-24 — Multiple UNH Form 4 filings dated 2026-09-24 in provided EDGAR window (transactions include code A awards on 2026-09-22 per dataset).
2026-10-01 — Multiple insiders reported code A grants/awards dated 2026-10-01 (per deterministic Form 4 activity list).
2026-10-05 — Multiple UNH Form 4 filings dated 2026-10-05 in provided EDGAR window (relating to 2026-10-01 grants/awards per deterministic list).
2026-10-13 — UNH filed 8-K reporting Q3 2026 results (Items 2.02, 9.01) with earnings release exhibit; earnings release states guidance raised for full year 2026.
2026-10-13 — Trade disclosure date for analyzed trade (per provided dataset).

Independent analysis of public financial disclosures. Not financial or investment advice.

Sources

Kevin Hern · UNH · Trading news